Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.
Apfel
S C
SC
Asbury
A K
AK
Bril
V
V
Burns
T M
TM
Campbell
J N
JN
Chalk
C H
CH
Dyck
P J
PJ
Dyck
P J
PJ
Feldman
E L
EL
Fields
H L
HL
Grant
I A
IA
Griffin
J W
JW
Klein
C J
CJ
Lindblom
U
U
Litchy
W J
WJ
Low
P A
PA
Melanson
M
M
Mendell
J R
JR
Merren
M D
MD
O'Brien
P C
PC
Rendell
M
M
Rizza
R A
RA
Service
F J
FJ
Thomas
P K
PK
Walk
D
D
Wang
A K
AK
Wessel
K
K
Windebank
A J
AJ
Ziegler
D
D
Zochodne
D W
DW
D002986:Clinical Trials as Topic / Q000379:methods; D003920:Diabetes Mellitus / Q000628:therapy; D003929:Diabetic Neuropathies / Q000175:diagnosis / Q000453:epidemiology* / Q000523:psychology; D023381:Endpoint Determination; D006801:Humans; D012678:Sensation Disorders / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology* / Q000523:psychology; D016896:Treatment Outcome